Michael L Jones Biocryst Pharmaceuticals Inc (BCRX) insider trading activity

Michael L Jones is Exec. Director, Finance - PAO of BIOCRYST PHARMACEUTICALS INC. Currently has a direct ownership of 16,653 shares of BCRX, which is worth approximately $139,718. The most recent transaction as insider was on Dec 19, 2022, when has been sold 5,900 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 16.7K

0% 3M change

0% 12M change

Total Value Held $139,718

Michael L Jones Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Date	Transaction	Value	Shares Traded	Shares Held	Form
Dec 19 2022	BUY Grant, award, or other acquisition	-	5,900 Added 26.16%	16,653 Common Stock
Dec 15 2022	SELL Open market or private sale	$4,850 $10.9 p/Share	445 Reduced 3.97%	10,753 Common Stock
Dec 01 2022	SELL Open market or private sale	$111,886 $13.01 p/Share	8,600 Reduced 43.44%	11,198 Common Stock
Dec 01 2022	BUY Exercise of conversion of derivative security	$12,212 $1.42 p/Share	8,600 Added 30.28%	19,798 Common Stock
Mar 01 2022	SELL Open market or private sale	$39,560 $17.2 p/Share	2,300 Reduced 17.04%	11,198 Common Stock
Mar 01 2022	BUY Exercise of conversion of derivative security	$10,879 $4.73 p/Share	2,300 Added 14.56%	13,498 Common Stock
Dec 14 2021	BUY Grant, award, or other acquisition	-	5,850 Added 34.31%	11,198 Common Stock
Mar 18 2021	BUY Exercise of conversion of derivative security	$15,795 $3.51 p/Share	4,500 Added 45.69%	5,348 Common Stock

MLJ

Michael L Jones

Exec. Director, Finance - PAO

Durham, NC

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BCRX shares.

Notify only if

Value

Any

Insider Trading

Get notified when an Biocryst Pharmaceuticals Inc insider buys or sells BCRX shares.

Notify only if

Operation

Any

Value

Any

Type

P - Open market or private purchase×

S - Open market or private sale×

V - Transaction voluntarily reported earlier than required×

A - Grant, award, or other acquisition×

D - Sale (or disposition) back to the issuer×

F - Payment of exercise price or tax liability×

I - Discretionary transaction×

M - Exercise of conversion of derivative security×

C - Conversion of derivative security×

E - Expiration of short derivative position×

H - Expiration (or cancellation) of long derivative position with value received×

O - Exercise of out-of-the-money derivative securities×

X - Exercise of in-the-money or at-the-money derivatives securities×

G - Bona fide gift×

L - Small Acquisition×

W - Acquisition or disposition by will or laws×

Z - Deposit into or withdrawal from voting trust×

J - Other acquisition or disposition×

K - Transaction in equity swap or similar instrument×

U - Disposition due to a tender of shares in a change of control transaction×

20 item(s) selected

News

Receive news related to BIOCRYST PHARMACEUTICALS INC

Track Activities on BCRX

Account